Loooong-acting islatravir shines in HIV prevention and treatment studies July 25, 2019 By Anette Breindl No Comments MEXICO CITY – Merck Sharp & Dohme's MK-8591, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), impressed in both treatment and prevention studies at the 2019 International AIDS Society (IAS) Conference on HIV Science.Read More